IBDEI0NH ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11556,2)
 ;;=^267253
 ;;^UTILITY(U,$J,358.3,11557,0)
 ;;=162.9^^79^761^25
 ;;^UTILITY(U,$J,358.3,11557,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11557,1,1,0)
 ;;=1^162.9
 ;;^UTILITY(U,$J,358.3,11557,1,2,0)
 ;;=2^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,11557,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,11558,0)
 ;;=191.9^^79^761^7
 ;;^UTILITY(U,$J,358.3,11558,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11558,1,1,0)
 ;;=1^191.9
 ;;^UTILITY(U,$J,358.3,11558,1,2,0)
 ;;=2^BRAIN CANCER
 ;;^UTILITY(U,$J,358.3,11558,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,11559,0)
 ;;=171.9^^79^761^50
 ;;^UTILITY(U,$J,358.3,11559,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11559,1,1,0)
 ;;=1^171.9
 ;;^UTILITY(U,$J,358.3,11559,1,2,0)
 ;;=2^SARCOMAS/OTH SOFT TISSUE CANCER
 ;;^UTILITY(U,$J,358.3,11559,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,11560,0)
 ;;=150.9^^79^761^16
 ;;^UTILITY(U,$J,358.3,11560,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11560,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,11560,1,2,0)
 ;;=2^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,11560,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,11561,0)
 ;;=153.9^^79^761^15
 ;;^UTILITY(U,$J,358.3,11561,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11561,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,11561,1,2,0)
 ;;=2^COLON CANCER
 ;;^UTILITY(U,$J,358.3,11561,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,11562,0)
 ;;=152.9^^79^761^55
 ;;^UTILITY(U,$J,358.3,11562,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11562,1,1,0)
 ;;=1^152.9
 ;;^UTILITY(U,$J,358.3,11562,1,2,0)
 ;;=2^SMALL INTESTINE CANCER
 ;;^UTILITY(U,$J,358.3,11562,2)
 ;;=^267077
 ;;^UTILITY(U,$J,358.3,11563,0)
 ;;=193.^^79^761^60
 ;;^UTILITY(U,$J,358.3,11563,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11563,1,1,0)
 ;;=1^193.
 ;;^UTILITY(U,$J,358.3,11563,1,2,0)
 ;;=2^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,11563,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,11564,0)
 ;;=284.9^^79^761^3
 ;;^UTILITY(U,$J,358.3,11564,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11564,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,11564,1,2,0)
 ;;=2^APLASTIC ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,11564,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,11565,0)
 ;;=170.9^^79^761^6
 ;;^UTILITY(U,$J,358.3,11565,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11565,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,11565,1,2,0)
 ;;=2^BONE AND CARTILAGE CANCER
 ;;^UTILITY(U,$J,358.3,11565,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,11566,0)
 ;;=175.9^^79^761^9
 ;;^UTILITY(U,$J,358.3,11566,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11566,1,1,0)
 ;;=1^175.9
 ;;^UTILITY(U,$J,358.3,11566,1,2,0)
 ;;=2^BREAST CANCER-MALE
 ;;^UTILITY(U,$J,358.3,11566,2)
 ;;=^267205
 ;;^UTILITY(U,$J,358.3,11567,0)
 ;;=209.10^^79^761^10
 ;;^UTILITY(U,$J,358.3,11567,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11567,1,1,0)
 ;;=1^209.10
 ;;^UTILITY(U,$J,358.3,11567,1,2,0)
 ;;=2^CARCINOID, LARGE INTESTINE
 ;;^UTILITY(U,$J,358.3,11567,2)
 ;;=^336722
 ;;^UTILITY(U,$J,358.3,11568,0)
 ;;=209.29^^79^761^11
 ;;^UTILITY(U,$J,358.3,11568,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11568,1,1,0)
 ;;=1^209.29
 ;;^UTILITY(U,$J,358.3,11568,1,2,0)
 ;;=2^CARCINOID,NONBOWEL AND OTH SITE
 ;;^UTILITY(U,$J,358.3,11568,2)
 ;;=^336507
 ;;^UTILITY(U,$J,358.3,11569,0)
 ;;=209.00^^79^761^12
 ;;^UTILITY(U,$J,358.3,11569,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11569,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,11569,1,2,0)
 ;;=2^CARCINOID,SMALL INTESTINE
 ;;^UTILITY(U,$J,358.3,11569,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,11570,0)
 ;;=156.9^^79^761^13
 ;;^UTILITY(U,$J,358.3,11570,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11570,1,1,0)
 ;;=1^156.9
